Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MRTTSE:6034 -0.95%63 Days Inventory is 10.30 as of Mar. 2026, which is 663% above its 10-year median of 1.35. GuruFocus rates TSE:6034 with a GF Score™ of 63/100 and a GF Value™ of 円630.26 (Fairly Valued). The stock has 4 warning signs investors should review. Among 497 Healthcare Providers & Services companies, MRT ranks better than 80.89% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). MRT's Average Total Inventories for the
three
months ended in Mar. 2026 was 円36 Mil. MRT's Cost of Goods Sold for the
three
months ended in Mar. 2026 was 円322 Mil.
Hence, MRT's Days Inventory for the
three
months ended in Mar. 2026 was 10.30.
The historical rank and industry rank for MRT's Days Inventory or its related term are showing as below:
TSE:6034'
s Days Inventory Range Over the Past 10 Years
Min: 0.38 Med: 1.35 Max: 10.8
Current: 10.43
During the past 12 years, MRT's highest Days Inventory was 10.80. The lowest was 0.38. And the median was 1.35.
TSE:6034's Days Inventory is ranked better than 80.89% of 497
companies
in the Healthcare Providers & Services industry
Industry Median: 29.67
vs TSE:6034: 10.43
MRT's Days Inventory
increased
from Mar. 2025 (7.94) to Mar. 2026 (10.30).
It might indicate that MRT's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
MRT's Inventory Turnover for the
three
months ended in Mar. 2026 was 8.86.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
MRT's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.04.
MRT (TSE:6034) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
MRT's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
MRT's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
MRT Days Inventory Related Terms
MRT Days Inventory Historical Data
* Premium members only.
The historical data trend for MRT's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:6034 vs HCA, THC, DVA: Days Inventory Comparison
For the Medical Care Facilities subindustry, MRT's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MRT Days Inventory vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, MRT's Days Inventory distribution charts can be found below:
* The bar in red indicates where MRT's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MRT (TSE:6034) has a Days Inventory of 10.30 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on MRT and its competitors. This is 663% above median its historical median of 1.35. Over the past decade, MRT's Days Inventory has ranged from 0.38 to 10.80. According to the industry distribution chart, MRT ranks #95 out of 497 companies in the Healthcare Providers & Services industry, placing it in the top 19.1%.
Is MRT's Days Inventory too high?
MRT's current Days Inventory of 10.30 is 663% above median its 10-year median of 1.35. Over the past 10 years, this metric has ranged from a low of 0.38 to a high of 10.80. The Healthcare Providers & Services industry median Days Inventory is 29.67. MRT's value of 10.30 is 65.3% below this industry median. Based on the distribution chart, MRT ranks #95 out of 497 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, MRT has a GF Score™ of 63/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does MRT's Days Inventory compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, MRT ranks #95 out of 497 companies for Days Inventory. This places MRT in the top 19% of its industry — outperforming the majority of peers. The industry median Days Inventory is 29.67. MRT's value of 10.30 is 65.3% below this benchmark. Historically, MRT's own Days Inventory has ranged from 0.38 to 10.80 over the past decade. While the company's 10-year median is 1.35 vs. the industry median of 29.67, MRT has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Healthcare Providers & Services company?
The median Days Inventory among Healthcare Providers & Services companies is 29.67, based on 497 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MRT's current Days Inventory of 10.30 is 65.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on MRT and its competitors. For the Healthcare Providers & Services industry, the median Days Inventory is 29.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MRT's current Days Inventory is 10.30, which is 663% above median its own 10-year median of 1.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MRT stock overvalued right now?
Based on GuruFocus' analysis, MRT (TSE:6034) is currently considered Fairly Valued. The stock's GF Value™ is 円630.26, compared to a current price of 円624.00 — trading 1% below its estimated fair value. The current Days Inventory is 10.30, which is 663% above median its 10-year median of 1.35 and 65.3% below the Healthcare Providers & Services industry median of 29.67. MRT's overall GF Score™ is 63/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For MRT (TSE:6034), the current Days Inventory is 10.30 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MRT (TSE:6034) Overvalued in 2026?
Based on GuruFocus' analysis, MRT stock appears to be undervalued.
The current stock price of 円624.00 is trading 1% below its estimated GF Value™ of 円630.26.
GuruFocus considers MRT to be Fairly Valued.
Key valuation signals for TSE:6034:
Days Inventory: 10.30 (663% above median its 10-year median of 1.35)
GF Value™: 円630.26 vs. price of 円624.00 (1% below fair value)
Industry Position: 65.3% below the Healthcare Providers & Services median (#95 of 497)
No single metric tells the full story. See the TSE:6034 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MRT Inc engages in the business of medical personnel placement services through the Internet. It provides part-time and full-time physician referral services through the physician referral site, as well as part-time job referral, job change introduction services to nurses, pharmacists, clinical laboratory technicians, clinical engineers, and radiologists. Further, the company engages in the research and development of analytical and analytical methods for various biological samples, such as microorganisms, blood, proteins, and genes; and research and development, manufacture, and sale of medical and medical examination equipment, and analytical instruments.
63GF Score
Get the complete analysis for TSE:6034
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:6034 has been successfully added to your 
